The present study examines the effects of phytohemagglutinin stimulation of a population of human (h) PBMC Phytohemagglutinin-treatment increases the plasma membrane pool size of M-sites with a concomitant reduction in the microsomal pool size without affecting the binding affinities or the total number of M-sites/cell. Data presented in this paper demonstrate that there a-e two pools of glucose transporters in these cells and phytohemagglutinin stimulation induces an energy-dependent net translocation of glucose transporters from an intracellular reserve pool to the plasma membrane, which accounts for > 60% of the increment in glucose transport.
Introduction
Plant lectins such as PHA trigger resting lymphocytes into metabolic activity. Several groups of investigators have shown that one of the earliest effects of the lectin binding to the lymphocyte is the enhancement in glucose transport (1) (2) (3) (4) (5) (6) (7) (8) . Peters and Hausen (1) have shown that increase in 3-0-methyl glucose (3-OMG)' uptake in lymphocytes was demonstrable within minutes of exposure to PHA and is independent of de novo protein synthesis. They also showed that the augmented transport in PHA-stimulated lymphocytes is due to an increase in the Vmx without significant change in the half-saturation constant (Ki). The authors interpreted these findings as an increase inthe number offunctional glucose carriers in the Con A, another lectin, and calcium ionophore (A23187) were also shown to stimulate glucose transport in calcium-dependent fashions in rat thymocytes (2, 4) . These early effects on glucose transport are independent of insulin since insulin receptors do not express themselves until 4 h or longer after PHA stimulation (3) .
The glucose transport in lymphocytes proceeds via a mechanism of facilitated diffusion similar to that in adipocytes (1) and is specifically inhibited by a fungal metabolite, cytochalasin B (CB) (9) . Recently, two groups of workers have provided evidence that the mechanism by which insulin enhances glucose transport in adipocytes involves net translocation of glucose carrier molecules from an intracellular pool to the outer plasma membrane (10, 1 1). Thus, it was interesting to investigate whether stimulation of glucose transport in lymphocytes immediately after 30-60 min of PHA treatment, a time period known to be too short for emergence ofa significant amount of insulin receptors, also involves a recruitment of glucose transporters from an intracellular storage pool to the cell surface.
The number of transport carrier molecules in adipocytes (10) and human erythrocytes (12) has been quantitated by measuring glucose-sensitive CB binding sites. Previously we have described three distinct classes of CB binding sites in a population of human (h) PBMC enriched in lymphocytes (-88% lymphocytes) and identified the medium-affinity site (M-site) that was specifically displaced by D-glucose as the glucose carrier (9, 13) . In the present study we first show that the M-site occurs not only in the plasma membrane but also in a microsomal fraction as an intracellular reserve pool. Second, we show that net translocation of M-sites from the microsomal reserve pool to the plasma membrane occurs upon stimulation with PHA. We also demonstrate that such recruitment accounts for a significant part (60%) of the augmentation in glucose transport that occurs immediately after PHA stimulation. Since we have studied transport effects without insulin and only during the first 30-60 min after PHA stimulation before emergence of insulin receptors, the observed effects include only the early effects of PHA on glucose transport that are not mediated by insulin.
Methods
Materials. Parker (14) . Mononuclear leukocytes were first prepared from these sources by Ficoll-Hypaque density gradient centrifugation as described previously from our laboratory (I15). The cell population was then depleted of adherent cells, monocytes, B cells, and platelets. For this, the mononuclear cells were suspended in medium 199 containing 10% human blood group AB serum (ABS) and incubated in a glass bottle previously coated with ABS for 1 h at 370C. The nonadherent cells were gently decanted. The suspension was centrifuged at low speed (200 g) for 10 min, and the pellet was resuspended in medium 199 and treated with 0.83% ammonium chloride for 5 min to lyse residual red blood cells and platelets. The cell suspension was again centrifuged at 200 g for 10 min and the pellet was washed once. At this point the composition of the cell population in the suspension was determined in four separate experiments. The cell population was found to consist of 88.0±2.7% (mean±SE) lymphocytes and 11.5±2.7% monocytes by examination of smears stained by Wright's stain. By using the Quantigen rosette assay (Ortho Pharmaceutical, Raritan, NJ), there were 74.0±2.2% T cells and 2.2±1.3% B cells in this population. This population will henceforth be referred to simply as hPBMC.
PHA treatment. Washed hPBMC were resuspended in medium 199 and incubated with and without PHA at 370 for 40 min before washing and subcellular fractionation (total time of exposure to PHA including washing 60 min). We chose to use PHA at a concentration of 5 ug/ml since in our laboratory peak DNA synthesis of stimulated cells is usually maximal at this concentration. For example, after 72 h culture of I05 lymphocytes under previously described conditions (9) , PHA at 5 ,ug/ml caused an increment in tritiated thymidine uptake over control (unstimulated hPBMC) of 14,823±2,304 (mean±SE, n = 3). At higher PHA concentrations the increment was less than maximal (8,699±1,992 cpm at 10 gg/ml) until toxic concentrations were reached. Subcellular fractionation. Cells were resuspended at a concentration of 107/ml in homogenization buffer (255 mM sucrose, 1 mM EDTA, and 10 mM Tris, pH 7.4, to be referred to as SET) and homogenized by 10 strokes of a Teflon-glass homogenizer (Thomas Scientific, Swedesboro, NJ). Subcellular fractions were prepared as described (16, 17) essentially following the procedure of Cushman and Wardzala (10) . The homogenate was centrifuged at 17,000 g for 15 min at 4°C, and the supernatant and pellet were saved. The pellet was washed and centrifuged at 1 10,000 g for 70 min in a discontinuous 1.12 M-sucrose gradient in 20 mM Tris HCl and 1 mM EDTA. The resulting plasma membrane-enriched band was washed twice by centrifugation at 48,000 g and resuspended in the assay buffer at a protein concentration of 3-5 mg/ml. The 17,000 g supernatant was centrifuged at 200,000 g for 70 min to yield the microsomal fraction as pellet, which was similarly resuspended in the assay buffer as described from our laboratory (16, 17 (17) was calculated from the difference in observed binding in the absence and presence of 500 mM D-glucose. Data were subjected to Scatchard plot analysis for the quantitation of M-sites. Where effects of low temperature were assessed, lymphocytes were incubated with and without PHA at 4VC for 40 min, followed by preparation of subcellular fractionation and measurement of CB binding as described above. Measurement oflactate production and A TP content. hPBMC were suspended in Dulbecco's buffered saline solution at a concentration of 2 X 106 cells/ml and incubated with and without PHA at 370C. The incubation was terminated after designated periods of time as given in the figures by addition of TCA to a final concentration of 6%. The assay mixture was vortexed, allowed to stand at 00C for 5 min, and centrifuged (1,000 g for 10 min). The supernatant fluid was used for determination of ATP and lactate (18) (19) (20) . For the measurement of ATP we took advantage of the fact that it reacts with 3-phosphoglycerate to form 1,3-diphospho-glycerate. The concentration of ATP is proportional to the amount of NADH reduced, which was monitored by the decrease in absorbance at 340 nm (18) . For the measurement of lactate, the supernatant fluid was incubated with lactate dehydrogenase in the presence of NAD, as described (20) . Lactate concentration in the sample was estimated by measurement of the increase in absorbance at 340 nm (20) . Appropriate concentrations of KCN or DNP were incorporated into the incubation medium for specific experiments as depicted in the relevant figures and legends. Measurement ofCO2 production from 'C-labeled glucose. Freshly purified hPBMC were suspended in KRB at a cell concentration of 15 X 106 cells/ml. Assay was performed in a 370C water bath in a flask of 2 ml of KRB containing 1 mg/ml of unlabeled D-glucose, 0.22 MCi/ml of U-["4C]glucose, and 10% ABS (20) . 1 ml of the cell suspension was added along with 10 til of PHA (final concentration 5 qg/ml) to begin the assay. Controls contained no cells (1 ml of KRB being added instead), the full assay mixture with cells but no isotope, and the full assay mixture with cells but no PHA. The incubation was continued for defined periods of time at 370C as described in Results, terminated by the addition of TCA, and incubated further for 1 h. Plastic wells were removed from the flasks and the radioactivity in the well was counted by liquid scintillation in 10 ml of Betafluor (National Diagnostics, Manville, NJ) (20 strated that activation of transport function in T lymphocytes with Con A and PHA is a rapid process (1-6). After 60 min of exposure to PHA, lactate and CO2 production from glucose were enhanced by 2.8 (P < 0.05, n = 3)-and 2.7 (P < 0.05, n = 3)-fold, respectively. Effects of a metabolic inhibitor on PHA-stimulated cells were shown in Fig. 1 , B and C. 1 mM DNP treatment inhibited CO2 production at 1 h by -60% in both control and PHA-treated cells (B). In C, treatment reduced ATP content in PHA-stimulated cells very rapidly by 40-50%. The effects of PHA on glucose transport were next studied by measuring equilibrium exchange flux of 3-OMG. Preliminary experiments in this study indicated that at 370C the equilibrium exchange is very rapid and therefore difficult to quantitate precisely. The rate of equilibration, however, was considerably reduced at 15'C so the entire 60-min time course of the exchange could be followed accurately. Such a temperature effect was also reported by Peters and Hansen in their original description ofthe effect ofPHA on glucose transport where the increment could be clearly shown only at 15'C (1). Results of a typical experiment are illustrated in Fig. 2 A, revealing that PHA treatment significantly increases the rate of 3-OMG exchange as compared with unstimulated controls. The time courses of equilibration, when analyzed based on simple equilibration in a closed, two-compartment system, revealed two distinct first-order components (a slow and a fast) for both unstimulated (control) and PHA-stimulated lymphocytes (Fig.  2 A inset) . For unstimulated hPBMC, the slow component Since it is known that lowering the temperature to 1 5IC by itself can cause some redistribution of glucose transporters to the plasma membrane pool in adipocytes, we did some experiments in which 2 mM KCN was added after incubation of cells in PHA for 30 min at 370C and incubation continued for 10 min at 370C. The temperature was then lowered to 15C
and equilibrium exchange of 3-MOG determined. Under these conditions both fast and slow flux components were still observed with t1/2 times of -3 and 15 min, respectively, for both unstimulated and stimulated cells. For unstimulated cells the relative sizes of the fast and slow transporting components in the first experiment constituted 25 and 75%, while in the second experiment the corresponding component sizes were 28 and 72%. For PHA-stimulated lymphocytes the fast and slow components were 48 and 52% in the first experiment and 45 and 55% in the second experiment, respectively. Thus, most of the PHA-induced increment was still observed when KCN was used before the temperature shift. Therefore, most of the augmentation in transport and the increase in the size of the fast transporting component is due to PHA stimulation and cannot be attributed entirely to temperature shift. To avoid temperature shift altogether in demonstrating increment in glucose transport, we performed experiments using 2DOG. Transport of 2DOG was comparatively slow at 370C (Fig. 2   B) . We were able to demonstrate a 1.8-2.0-fold increase in 2DOG uptake due to PHA stimulation at 37°C.
We have previously identified medium affinity D-glucose displaceable CB binding sites (M-sites) in hPBMC and presented evidence that these sites are the glucose transport carrier (9) . Results in Fig. 3 show that the D-glucose displacement CB binding sites are found not only in the plasma membrane fraction but also in the microsomal membrane fraction of un- (Table II) . Unlike the effects observed at 00C neither DNP nor KCN totally obliterate the apparent redistribution of M-sites. This is probably related to the fact that anaerobic metabolism generates a significant amount of ATP in hPBMC as evidenced by data presented in Fig. 1 .
The data presented in Table III show that PHA treatment does not alter the specific activity of 5'-nucleotidase (5'-NT) or the yield of protein in any of the subcellular fractions.
Discussion
Translocation of glucose carrier from an intracellular reserve pool to the plasma membrane pool as a major transport regu- latory mechanism has been demonstrated in insulin-sensitive systems such as adipocytes (10, I 1) and muscle cells (21) (22) (23) (24) . Translocation of other types of transport carrier molecules has also been observed in stimulus-response systems that are not insulin dependent. Gluck et al. (25) have presented evidence of translocation of proton pump ATPase molecules when turtle bladder epithelium is stimulated to excrete acid by exposure to CO2. Our data constitutes the first demonstration of translocation of glucose carrier in lymphoid cells mediated by a mitogenic stimulus. This supports the possibility of commonality of this translocation mechanism in a wider variety of stimulus-response systems. Our data clearly demonstrate that there is an authentic intracellular storage pool of glucose transporters (M-sites) in hPBMC. That this is not simply the contamination of plasma membrane is supported by the findings summarized in Table  III . For unstimulated lymphocytes the specific activities of 5'-NT, a plasma membrane-specific enzyme marker in the microsomal fraction, is only 15% of that found in the plasma membrane fraction, indicating that contamination of plasma membrane in microsomal fraction is not more than 15%. The maximum limit for contamination may be significantly less than this value, as 5'-NT is not present exclusively in the plasma membrane in rat lymphocytes, but is also found in an intracellular compartment although at a lower specific activity (26) . The corresponding M-site concentration ratio calculated from values of BT in pmol/mg protein in these two fractions for control cells is 0.37. This is much greater (> twofold) than the 0.15 calculated maximum plasma membrane contamination of the microsomal fraction. Therefore, the observed Msite content in the microsomal fraction cannot be explained by the cross-contamination alone.
Three lines of evidence presented further establish the occurrence of translocation of M-sites within 60 min of PHA (10, 1) . Finally, we have also presented evidence that the total number of glucose transporters/cell is unaffected in the first 60 min after PHA stimulation, which excludes significant increase due to synthesis of new glucose transporters during this brief time period. In the hPBMC, unlike in adipocytes, the concentration (specific activity) of M-sites in plasma membrane fraction is about threefold higher than that in the microsomes. Therefore, correction for contamination of plasma membrane fraction (with its relatively high specific activity of M-sites of 88-103 pmol/mg protein) with microsomes that have a lower density of M-sites (30-35 pmol/mg protein) would, if anything, raise the concentration of M-sites in plasma membrane to an even higher level. Precise estimation of microsomal contamination in the plasma membrane fraction is, therefore, not essential either for the demonstration ofthe authentic microsomal pool of glucose transporters or for demonstration of the occurrence of translocation. Despite considerable effort we have not yet been able to find a specific microsomal enzyme marker in hPBMC since the NADH:cytochrome c as well as glucose-6-phosphate phosphatase, the conventional microsomal markers, were found to exist indigenously in significant concentrations in the purified plasma membrane (data not presented). There is evidence that NADH-cytochrome c reductase may not be a specific marker of microsomal fraction since the possibility exists that this enzyme may exist indigenously in the plasma membrane. Indeed, highly purified rat liver plasma membranes and Golgi apparatus have been shown to contain this enzyme with specific activities of 10 and 25% ofthat in the endoplasmic reticulum (27) . In the rat adipocyte it has been assumed that the indigenous NADH-cytochrome c reductase specific activity of the plasma membrane fraction may be 20% of that in uncontaminated microsomal membrane (10) . In the absence of specific enzyme markers and detailed knowledge of the precise subcellular distribution of individual marker enzymes in human lymphocytes, precise quantitative estimation ofcross-contamination ofplasma membrane with microsomal fractions was not possible.
Whitesell et al. (2, 4) demonstrated that resting rat T lymphocytes consist of two populations defined by glucose transport rate only (e.g., a "quiescent" and an "active" subset). Further, mitogenic stimulation converted a significant fraction of the quiescent subset to the active status (2, 4) . Our 3-OMG equilibrium exchange data (Fig. 2 A) (Fig. 2) and the cellular M-sites were not increased (see above), the overall M-site plasma membrane pool size must have increased from 180 to 260 U/I00 cells. This is an increase of 44%. The observed increase in M-sites in the plasma membrane was 26% (Table III) , indicating that carrier translocation explains 60% of the increment in glucose transport caused by PHA. Simpson et al. have presented evidence that translocation of glucose transporters represents only one component in a complex mechanism through which insulin regulates glucose transport in adipocytes (28) . It appears that in the PHA-stimulated human lymphocyte mechanisms other than translocation may play a role in augmenting glucose transport. 3-OMG equilibrium exchange was measured at 15'C, unlike all other experiments including translocation reported here, which were performed at 370C exclusively. Our estimates of glucose transport are based on the assumption that the increment due to PHA at 370C is proportional to the increment when the experiment is performed at 15'C, as it was here.
The temperature shift to 1 5'C by itself is known to cause redistribution of glucose transporters in rat adipocytes, which can be prevented by treatment of cells with KCN (2 mM) (29) . However, we have shown that the increment in glucose transport caused by PHA was well preserved when cells were treated with KCN after PHA treatment before lowering temperature to 150C. Therefore, under the conditions used, the temperature shift cannot be responsible for most of the observed increment. Similar calculation made from the data after KCN treatment (not shown) essentially led to a similar conclusion. Data of 2-deoxy-glucose uptake measured at 370C (Fig. 2 B) support the possibility that translocation mechanism can explain up to 25-30% of the PHA-induced increment in transport. We should state that quantitative analysis of net 2DOG uptake data in terms of transport is complicated due to its phosphorylation and to the fact that net uptake but not equilibrium exchange is being measured.
